Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V0DI
|
|||
Former ID |
DIB006887
|
|||
Drug Name |
CT-2584
|
|||
Synonyms |
Apra (Cell Therapeutics, US, US); 1-[11-(Dodecylamino)-10-hydroxyundecyl]-3,7-dimethylxanthine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 3 | [1] | |
Company |
Cell Therapeutics
|
|||
Structure |
Download2D MOL |
|||
Formula |
C30H55N5O3
|
|||
Canonical SMILES |
CCCCCCCCCCCCNCC(CCCCCCCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O
|
|||
InChI |
1S/C30H55N5O3/c1-4-5-6-7-8-9-10-13-16-19-22-31-24-26(36)21-18-15-12-11-14-17-20-23-35-29(37)27-28(32-25-33(27)2)34(3)30(35)38/h25-26,31,36H,4-24H2,1-3H3
|
|||
InChIKey |
MZNMZWZGUGFQJP-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 166981-13-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cholinephosphate cytidylyltransferase (PCYT1B) | Target Info | Modulator | [1] |
KEGG Pathway | Glycerophospholipid metabolism | |||
Metabolic pathways | ||||
Choline metabolism in cancer | ||||
Pathwhiz Pathway | Phospholipid Biosynthesis | |||
WikiPathways | Acetylcholine Synthesis | |||
Glycerophospholipid biosynthesis |
References | Top | |||
---|---|---|---|---|
REF 1 | Pharmacological inhibition of phosphatidylcholine biosynthesis is associated with induction of phosphatidylinositol accumulation and cytolysis of neoplastic cell lines. Cancer Res. 2000 Sep 15;60(18):5204-13. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.